| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT05272046 Monopolar and Bipolar Current RFA Knife in POEM |
Trial completed |
| 2026-06-09 | NCT05272046 Monopolar and Bipolar Current RFA Knife in POEM |
date change Primary completion moved earlier: 2026-11-19 -> 2024-02-19 |
| 2026-06-09 | NCT05272046 Monopolar and Bipolar Current RFA Knife in POEM |
date change Completion moved earlier: 2026-12-01 -> 2025-10-10 |
| 2026-06-03 | NCT05881759 Integrating Food Rx With Best Feeding Practices With EFNEP |
date change Primary completion pushed: 2026-03-31 -> 2027-03-31 |
| 2026-06-03 | NCT05881759 Integrating Food Rx With Best Feeding Practices With EFNEP |
date change Completion pushed: 2026-03-31 -> 2027-03-31 |
| 2026-05-19 | NCT07220993 Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car… |
Recruitment opened |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07508124 | Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male… | Urinary Tract Infection | Recruiting |
| NCT07368595 | Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With… | Dry Eye Disease (DED) | Not Yet Recruiting |
| Phase 2 | |||
| NCT06888128 | State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for… | PTSD | Recruiting |
| NCT06435286 | Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in… | Suspected or Known Squamous Cell Neoplasia | Recruiting |
| NCT05355272 | Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) | Gulf War Syndrome | Recruiting |
| NCT04626024 | Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A… | Chronic Myeloid Leukemia | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06329596 | Microbiome Alterations With Xylitol (MAX) in Pregnancy | Dysbiosis | Active, Not Recruiting |
| Phase 1 | |||
| NCT01853631 | Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell… | Non-Hodgkin Lymphoma | Recruiting |
| NCT04995003 | HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in… | Sarcoma | Recruiting |
| NCT06815432 | GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma | Glioblastoma Multiforme of Brain | Recruiting |
| NCT03740256 | Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST… | Bladder Cancer | Recruiting |
| NCT02291848 | Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma | Multiple Myeloma | Recruiting |
| NCT01555892 | Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE | Hodgkin's Disease | Recruiting |
| NCT04715191 | Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in… | Liver Cancer | Recruiting |
| NCT06176690 | Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive… | CD30-Positive Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT04099797 | C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) | Diffuse Intrinsic Pontine Glioma | Recruiting |
| NCT01940757 | Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator… | Hookworm Infection | Recruiting |
| NCT07220993 | Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car… | T-cell Acute Lymphoblastic Lymphoma | Recruiting |
| NCT02917083 | CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) | Hodgkin's Lymphoma | Recruiting |
| NCT04288726 | Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas | Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type | Recruiting |
| NCT04013802 | TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post… | Viral Infection | Recruiting |
| NCT04377932 | Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells… | Liver Cancer | Active, Not Recruiting |
| NCT00902044 | Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma | Sarcoma | Active, Not Recruiting |
| NCT02065362 | TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal… | EBV-positive Nasopharyngeal Carcinoma | Active, Not Recruiting |
| NCT00586391 | CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL &… | B Cell Lymphoma | Active, Not Recruiting |